Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02025543 · ClinicalTrials.gov registry record
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 207
- Enrollment target
NCT02025543: Completed study, sponsored by University of Wisconsin, Madison.
NCT02025543 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02025543 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
Study Summary
The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.
Primary Outcome
The hypothesis is that equivalence between R2 measured with different protocols with higher repeatability than standard MRI iron imaging measurement and with linear calibration to liver iron concentration will be demonstrated. This project will be considered a success if the reproducibility of confounder-corrected R2 MRI is established: the hypothesis is that calibrations at all sites will be equivalent.
Interventions
- DEVICE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2015-08-12 |
| Est. Completion | 2019-09 |
What the finished NCT02025543 record still lists
NCT02025543 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02025543 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02025543 about?
NCT02025543 is a clinical study titled "Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content". The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.
What is the current status of trial NCT02025543?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2015-08-12. Estimated completion is 2019-09.
What interventions are being tested in trial NCT02025543?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT02025543?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI